Get the Stockscreener App
19.37
0.31%
-0.06
After Hours:
19.37
Innoviva Inc stock is traded at $19.37, with a volume of 623.91K.
It is down -0.31% in the last 24 hours and down -3.58% over the past month.
Innoviva Inc is a company with a portfolio of royalties healthcare assets. It has three primary sets of assets: a royalty portfolio, operating assets in critical care and infectious disease, and other strategic healthcare assets. Its product offering includes Relvar/Breo/Ellipta, Anoro, Ellipta, Trelegy, Ellipta and others.
See More
Previous Close:
$19.43
Open:
$19.34
24h Volume:
623.91K
Relative Volume:
0.73
Market Cap:
$1.22B
Revenue:
$384.03M
Net Income/Loss:
$38.65M
P/E Ratio:
62.48
EPS:
0.31
Net Cash Flow:
$196.35M
1W Performance:
-5.42%
1M Performance:
-3.58%
6M Performance:
+11.26%
1Y Performance:
-1.22%
1-Day Range:
$19.16
$19.48
1-Week Range:
$19.11
$20.62
52-Week Range:
$16.67
$22.00
Innoviva Inc Stock (INVA) Company Profile
Name
Innoviva Inc
Sector
Industry
Phone
(650) 238-9600
Address
1350 OLD BAYSHORE HIGHWAY, BURLINGAME
Compare INVA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
INVA
Innoviva Inc
|
19.37 | 1.25B | 384.03M | 38.65M | 196.35M | 0.31 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Innoviva Inc Stock (INVA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-11-25 | Initiated | Oppenheimer | Outperform |
| Jul-14-25 | Initiated | H.C. Wainwright | Buy |
| Jul-11-25 | Initiated | Cantor Fitzgerald | Overweight |
| Mar-07-25 | Initiated | Scotiabank | Sector Outperform |
| Jun-18-24 | Initiated | Cantor Fitzgerald | Overweight |
| Jul-20-22 | Initiated | Goldman | Neutral |
| Nov-20-17 | Initiated | Deutsche Bank | Hold |
View All
Innoviva Inc Stock (INVA) Latest News
Innoviva (NASDAQ:INVA) Stock Rating Lowered by Wall Street Zen - Defense World
Innoviva, Inc. $INVA Shares Sold by Bridgeway Capital Management LLC - MarketBeat
Trexquant Investment LP Makes New $948,000 Investment in Innoviva, Inc. $INVA - MarketBeat
Price momentum metrics for Innoviva Inc. explained2025 Earnings Impact & Real-Time Volume Analysis Alerts - Newser
Historical volatility pattern of Innoviva Inc. visualizedPortfolio Return Report & Free Technical Confirmation Trade Alerts - Newser
Applying Elliott Wave Theory to Innoviva Inc.July 2025 Gainers & Precise Buy Zone Identification - Newser
Is Innoviva Inc. forming a bottoming baseEarnings Miss & Short-Term High Return Strategies - Newser
Is Innoviva Inc. stock entering bullish territoryInsider Buying & High Conviction Investment Ideas - Newser
Applying big data sentiment scoring on Innoviva Inc.July 2025 Big Picture & Smart Swing Trading Alerts - Newser
How to forecast Innoviva Inc. trends using time series2025 Volatility Report & Intraday High Probability Alerts - Newser
Can technical indicators confirm Innoviva Inc.’s reversalWeekly Trade Report & Weekly Hot Stock Watchlists - Newser
What’s the recovery path for long term holders of Innoviva Inc.2025 Price Momentum & Reliable Volume Spike Trade Alerts - Newser
Why Innoviva Inc. is moving todayMarket Activity Report & Weekly Breakout Stock Alerts - Newser
Multi asset correlation models including Innoviva Inc.Weekly Trend Summary & Comprehensive Market Scan Insights - Newser
Will Innoviva Inc. price bounce be sustainableQuarterly Profit Report & Safe Capital Preservation Plans - Newser
Relative strength of Innoviva Inc. in sector analysisCPI Data & Community Consensus Stock Picks - Newser
Pattern recognition hints at Innoviva Inc. upsideJuly 2025 Highlights & Growth Oriented Trade Recommendations - Newser
Volume spikes in Innoviva Inc. stock – what they meanJuly 2025 Closing Moves & Free High Return Stock Watch Alerts - Newser
Is it too late to sell Innoviva Inc.Weekly Trade Analysis & Accurate Technical Buy Alerts - Newser
How to monitor Innoviva Inc. with trend dashboards2025 Analyst Calls & Free Community Supported Trade Ideas - Newser
Is Innoviva Inc. meeting your algorithmic filter criteriaWeekly Trend Report & Low Risk High Reward Trade Ideas - Newser
Investors Appear Satisfied With Innoviva, Inc.'s (NASDAQ:INVA) Prospects - 富途牛牛
We Think Innoviva (NASDAQ:INVA) Can Manage Its Debt With Ease - simplywall.st
Has Innoviva Inc. found a price floorWeekly Stock Recap & Target Return Focused Picks - Newser
New Vernon Capital Holdings II LLC Has $4.31 Million Stake in Innoviva, Inc. $INVA - MarketBeat
Published on: 2025-09-11 02:52:34 - Newser
Comparing Novo Nordisk A/S (NYSE:NVO) & Innoviva (NASDAQ:INVA) - Defense World
What does recent volatility data suggest for Innoviva Inc.Day Trade & AI Enhanced Execution Alerts - Newser
Visual analytics tools that track Innoviva Inc. performanceWeekly Market Outlook & Expert Curated Trade Setups - Newser
What to do if you’re stuck in Innoviva Inc.Inflation Watch & Fast Exit and Entry Strategy Plans - Newser
Does Innoviva Inc. fit your quant trading modelTrade Signal Summary & Safe Investment Capital Preservation Plans - Newser
Innoviva Inc Stock (INVA) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):